Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000049

Chief Legal Officer gave up 1,129 shares (to pay taxes)

  • Chief Legal Officer acquired 3,833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Burns James William · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-01 Exercise or conversion : show line 1 in the form +3,833 27,371 D
2023-03-03 Shares withheld for taxes : show line 2 in the form −1,129 $25.02 $28,248 26,242 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-03-01 Grant or award : show line 3 in the form Restricted stock units +12,000 12,000 D
2023-03-01 Grant or award : show line 4 in the form Stock options (right to buy) +44,000 44,000 D
2023-03-01 Exercise or conversion : show line 5 in the form Restricted stock units −3,833 7,667 D
Loading xslF345X03/wf-form4_167787758550061.xml…